A major review of nearly 800,000 men has found prostate cancer screening using a specific test is likely to reduce deaths ...
A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.
Prostate cancer screening likely to reduce deaths but experts remain uncertain due to possible risks
The number of deaths from prostate cancer is likely to be reduced thanks to screening for the disease, but experts have ...
Prostate cancer is one of the most common cancers that occur in men. While it can be life-threatening, the disease is treatable, and the earlier it is detected, the better the treatment outcome.
This article was reviewed by Darragh O’Carroll, MD. Prostate-specific antigen (PSA) is a term you’ll probably become familiar with once you start getting screened regularly for prostate cancer ...
Q: I am 84 years old and just got a new doctor. When I asked her about the prostate exam my previous doctor did every few years, she seemed dismissive, saying, “Oh, we don’t do that anymore.” Is this ...
Patented Algorithm Designed to Help Identify Otherwise Dangerous Prostate Tumors Earlier Using Repeat Blood Test Results Licensing Agreement Expands 20/20 BioLabs’ AI-Enabled Multi-Cancer Early ...
Testosterone replacement therapy improved function without PSA recurrence in prostate cancer survivors with hypogonadism.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results